Opportunity timeline

PostedSep 3, 2026
DeadlineSep 24, 2026

In plain English

The Defense Health Agency is seeking pharmaceutical quotes for six newly approved drugs to consider for the Department of War Uniform Formulary. Potential agreements include Uniform Formulary Blanket Purchase Agreements and additional discount program agreements. A pre-quotation teleconference is scheduled for September 9, 2026; the RFQ lists the response deadline and contact details.

About this opportunity

The Department of War (DoW) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoW Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoW Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary…

Time remaining

Closes Sep 24, 2026

10Days
:
13Hours
:
46Min
:
24Sec

Related Opportunities

Bid details are gathered and summarized automatically. Please verify details at the original source.

Ref No.

BS-7F6685